Is the approval of Isentress one small step for HIV treatment, or is it a giant leap?
I think it’s a big hop. I really am encouraged by this. I like that this is a medication that works in a completely different way. I like that it’s a medication that doesn’t need pharmacological boosting with another drug — meaning it doesn’t require another drug to be as effective as it could be. It’s likely that this drug will mix well with others. I think that, generally, this is a very, very exciting step. We are bound historically by what drugs came out first. We use a lot of AZT [brand name: Retrovir; generic name: zidovudine] and like drugs, because they were the initial drugs. If they were to come out now, we might not be using them as much as we do. It’s historic. That this drug comes out, it’s in a new class — were this to have come out 10 years ago, this might be something we’d be using all the time. We would be. I think that this is a real, big advance and I am very encouraged by it. I think this is a bigger advance than having maraviroc, the new CCR5 inhibitor, come out.
Related Questions
- On the continuum of Windows upgrade importance from Windows 95 (a giant leap forward) to Windows Me (a step backward), where does Vista belong?
- Are human placental bed giant cells merely aggregates of small mononuclear trophoblast cells?
- Which Step Of Drinking-water Treatment Process Are Disease-causing Microorgams Killed?
